Pharmacokinetic and safety evaluation of SangCya vs Neoral or Sandimmune in stable renal transplant recipients

被引：6
|
作者：
Gaston, R [1 ]
Alloway, RR
Gaber, AO
Rossi, SJ
Schroeder, TJ
Irish, WD
Canafax, DM
First, MR
机构：
[1] Univ Alabama, Tuscaloosa, AL 35487 USA
[2] Univ Cincinnati, Cincinnati, OH 45221 USA
[3] Univ Tennessee, Knoxville, TN 37996 USA
[4] SangStat Med Corp, Menlo Park, CA USA
来源：
TRANSPLANTATION PROCEEDINGS | 1999年 / 31卷 / 1-2期
关键词：
D O I：
10.1016/S0041-1345(98)01647-9
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：326 / 327
页数：2
相关论文
共 50 条
  • [21] Safety and tolerability of Sandimmune Neoral vs Sandimmune in de novo renal transplant patients after 24 months' treatment
    Buchholz, B
    Korn, A
    [J]. TRANSPLANTATION PROCEEDINGS, 1996, 28 (04) : 2187 - 2188
  • [22] COMPARISON OF THE PHARMACOKINETICS OF CYCLOSPORINE SANDIMMUNE WITH SANDIMMUNE-NEORAL IN STABLE RENAL-TRANSPLANT PATIENTS
    SKETRIS, IS
    LAWEN, JG
    BEAUREGARDZOLLINGER, L
    BELITSKY, P
    LANDSBERG, D
    GIVNER, ML
    KEOWN, P
    [J]. TRANSPLANTATION PROCEEDINGS, 1994, 26 (05) : 2961 - 2963
  • [23] Conversion from Sandimmune to Neoral in renal transplant:: Functional histopathological, and pharmacokinetic changes
    Roessler, E
    Herrera, S
    Espinoza, M
    Ayala, A
    Reynolds, E
    González, F
    Espinoza, O
    Undurraga, A
    Muñoz, R
    Arcos, O
    Galaz, G
    [J]. TRANSPLANTATION PROCEEDINGS, 1998, 30 (05) : 1756 - 1757
  • [24] Safety and tolerability of Neoral vs Sandimmune: 1-year data in primary renal allograft recipients
    Barone, G
    Bunke, CM
    Choc, MG
    Hricik, DE
    Jin, JHJ
    Klein, JB
    Marsh, CL
    Min, DI
    Pescovitz, MD
    Pollak, R
    Pruett, TL
    Stinson, JB
    Thompson, JS
    Vasquez, E
    Waid, T
    Wombolt, DG
    Wong, RL
    [J]. TRANSPLANTATION PROCEEDINGS, 1996, 28 (04) : 2183 - 2186
  • [25] Case studies: Conversion from Sandimmune to Neoral in stable renal allograft recipients
    Roth, D
    Miller, J
    [J]. TRANSPLANTATION PROCEEDINGS, 1996, 28 (04) : 2219 - 2220
  • [26] Comparative pharmacokinetic study of neoral vs sandimmun in Japanese stable renal allograft recipients
    Takahara, S
    Ohta, K
    Ohashi, Y
    Namii, Y
    Uchida, K
    Okuyama, A
    Kainuma, H
    Takagi, H
    Takahashi, K
    Morikawa, H
    [J]. TRANSPLANTATION PROCEEDINGS, 1999, 31 (07) : 3089 - 3092
  • [27] A prospective study on conversion from Sandimmune to Neoral in stable adult liver transplant recipients
    Jain, A
    Gadomski, M
    Fung, J
    [J]. DIGESTIVE DISEASES AND SCIENCES, 1999, 44 (04) : 775 - 777
  • [28] Conversion from cyclosporine sandimmune to cyclosporine neoral in the stable renal transplant population
    Griffin, PJA
    Moore, RH
    Jurewicz, WA
    Lord, RHH
    Webley, Y
    Jenkins, J
    [J]. TRANSPLANTATION PROCEEDINGS, 1997, 29 (1-2) : 303 - 303
  • [29] Pharmacokinetic, hemodynamic, and metabolic effects of cyclosporine sandimmune versus the microemulsion neoral in heart transplant recipients
    White, M
    Pelletier, GB
    Tan, A
    Jesina, C
    Carrier, M
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 1997, 16 (08): : 787 - 794
  • [30] A Prospective Study on Conversion from Sandimmune to Neoral in Stable Adult Liver Transplant Recipients
    Ashok Jain
    Mary Gadomski
    John Fung
    [J]. Digestive Diseases and Sciences, 1999, 44 : 775 - 777
12345